C12orf60 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25307
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein C12orf60 using the following amino acid sequence: EKDKERLIQAAKMFFFHVQDLASVINTLTELFSRSMNTQILLMAVKNNSYIKDFFEQMLRIFKEMQSVVDARHDKIQKESLCSKV
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for C12orf60 Antibody
Immunocytochemistry/Immunofluorescence: C12orf60 Antibody [NBP3-25307]
Staining of human cell line Rh30 shows localization to cytosol & vesicles.Applications for C12orf60 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: C12orf60
Alternate Names
chromosome 12 open reading frame 60, hypothetical protein LOC144608, MGC47869
Gene Symbol
C12ORF60
Additional C12orf60 Products
Product Documents for C12orf60 Antibody
Product Specific Notices for C12orf60 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...